Status:
UNKNOWN
Oral Contraceptive During Menopausal Transition
Lead Sponsor:
Samsung Medical Center
Conditions:
Perimenopause
Eligibility:
FEMALE
45-60 years
Phase:
NA
Brief Summary
Muscle or joint pain is one of the most common symptoms during menopausal transition. As this could be severe enough to affect social and daily life and to reduce quality of life, attentions should be...
Eligibility Criteria
Inclusion
- Perimenopausal women aged 45 or more
- Women who have multiple joint or muscle pain for at least 3 months (at least two sites out of upper and lower extremities or axial)
Exclusion
- Rheumatoid arthritis, ankylosing spondylitis, rheumatic polymyalgia, Inflammatory myopathy
- pregnancy
- History of hysterectomy or bilateral oophorectomy
- Vasomotor symptoms
- History of surgery of musculoskeletal system
- History of cancer
- Abnormalities of thyroid function
- Focal neurologic deficit
- Smoking within 1 year
- Uncontrolled hypertension
- Coronary heart disease
- Diabetes mellitus
- Stoke
- Active thromboembolism
- Undiagnosed vaginal bleeding
- Acute hepatic dysfunction
- Gastrointestinal ulcer
- Severe renal dysfunction
- Hypersensitivity to drugs
- Current hormone user or past users within 3 months
Key Trial Info
Start Date :
April 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
52 Patients enrolled
Trial Details
Trial ID
NCT01414530
Start Date
April 1 2010
Last Update
September 10 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Samsung Medical Center
Seoul, Gangnam-gu, South Korea, 135-710